Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 2002

View Archived Issues

Angiogenix demonstrates angiogenic activity in preclinical trials

New data on the tolerability of gimatecan discussed at ESMO 2002

Chemotherapy-induced neuropathy reported to improve with levocarnitine acetyl hydrochloride

Marine-derived cytotoxic agents a highlight of the ESMO 2002 congress

Lack of efficacy of venlafaxine in fibromyalgia reported at ACR meeting

Vitaxin inhibits alphavbeta3 integrin expression in human synovial tissue engrafted in SCID mice

Pharmacopeia researchers design novel FSH modulators

New viral RNA polymerase inhibitors covered by BioCryst patent

Gruenenthal prepares and tests new antibacterial beta-lactam-siderophore conjugates

Novel triptolide prodrugs and their use in cancer and autoimmune diseases

Novartis claims malate salts of antifungal agent

Series of antiangiogenic and vascular-damaging agents under study at AstraZeneca

Guilford submits amendment to Gliadel Wafer sNDA

Semisynthetic ciclosporin derivatives for use in respiratory disorders prepared at Enanta

Ribapharm submits IND for Hepavir B

Enrollment begins in pivotal phase III trials of Atrisone for acne

Elan returns rights to HCV antisense drug to Isis

Isis and Elan extend collaboration in OraSense joint venture to end of year

Potential new antidementia drug from Fujisawa facilitates hippocampal neurotransmission

BSF-4007877 and BSF-4094664: neuroprotective 5-HT1A receptor agonists

Highly potent and selective 5-HT6 antagonist from Lilly is orally bioavailable and enters the brain

INO-1001 protects rats from ischemic stroke via inhibition of PARP

Erbitux clinical development program update

GPI-1485 enters new phase II trial in Parkinson's disease patients

December date set for advisory committee review of Bexxar

Fujisawa presents a potent new antioxidant, FR-210575, with potential in stroke

Myfortic receives first major approval in Switzerland

Orphan drug status granted for P-113D

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...